Literature DB >> 11711740

Colonic J-pouch function in rectal cancer patients: impact of adjuvant chemoradiotherapy.

P Gervaz1, N Rotholtz, S D Wexner, S Y You, N Saigusa, E Kaplan, M Secic, E G Weiss, J J Nogueras, B Belin.   

Abstract

PURPOSE: The colonic J-pouch technique of reconstruction optimizes functional outcome after proctectomy with coloanal anastomosis. However, the impact of adjuvant chemoradiation therapy on pouch function in rectal cancer patients has not been investigated.
METHODS: From January 1994 to December 1999, 74 patients with midrectal or low rectal tumors (less than 10 cm from the anal verge) underwent a proctectomy with coloanal anastomosis with colonic J-pouch reconstruction. Chemoradiation was offered in patients with Stage II and III disease. Radiation therapy was administered using a four-field technique including the anal canal, for a total dose of 50.4 Gy (1.8 Gy/fraction/day). Fifteen patients (20 percent) died with metastatic disease, five (6.8 percent) died of other causes without evidence of recurrence, and five (6.8 percent) were lost to follow-up. In addition, two patients had local recurrence (2.7 percent) at the time of follow-up. Forty-five of 47 eligible patients (96 percent) responded to a questionnaire designed to evaluate specifically the degree of continence and pouch evacuation.
RESULTS: The mean age of patients was 68.9 (range, 42-88) years and the mean duration of follow-up was 28.8 (range, 1-69) months. There were 28 patients in the surgery alone group and 17 patients who received either preoperative (13) or postoperative (4) adjuvant chemoradiation therapy. Patients in the surgery alone group had a significantly better degree of continence (mean +/- standard deviation continence score: 18.1 +/- 2.9 vs. 13.3 +/- 4.1, P < 0.001) and were less likely to experience evacuatory problems (mean +/- standard deviation evacuation score: 21.3 +/- 3.7 vs. 16.4 +/- 3.5, P < 0.001). Use of a pad was more frequent in the chemoradiation therapy than in the surgery alone group (53 vs. 18 percent, P = 0.02). The incidence after functional disorders was also more frequent in the irradiated group of patients: incontinence to gas (76 vs. 43 percent, P = 0.03), to liquid stool (64 vs. 25 percent, P = 0.01), and to solid stool (47 vs. 11 percent, P = 0.01). Moreover, irradiated patients reported more frequent pouch-related specific problems, such as clustering (82 vs. 32 percent, P = 0.001), and sensation of incomplete evacuation (82 vs. 32 percent, P = 0.001). Finally, regression analysis demonstrated that radiation-induced sphincter dysfunction was progressive over time.
CONCLUSIONS: Both preoperative and postoperative chemoradiation therapy adversely affects continence and evacuation in patients with colonic J-pouch. Because radiation-induced damage to the normal tissues is known to be cumulative over time, long-term progressive dysfunction of the anal sphincter and neorectum are causes of concern. Consideration should be given to excluding the anal canal from the field of irradiation in patients with Stage II and III rectal cancer, whenever a sphincter-preserving procedure is planned.

Entities:  

Mesh:

Year:  2001        PMID: 11711740     DOI: 10.1007/bf02234388

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  9 in total

1.  [Reconstructive surgery after anterior resection of the rectum].

Authors:  S Willis; V Schumpelick
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

2.  Long-term functional outcome of colonic J-pouch reconstruction after low anterior resection for rectal cancer.

Authors:  Jin-Ichi Hida; Takehito Yoshifuji; Kiyotaka Okuno; Tomohiko Matsuzaki; Toshihiro Uchida; Eizaburou Ishimaru; Tadao Tokoro; Masayuki Yasutomi; Hitoshi Shiozaki
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

Review 3.  Function preservation in rectal cancer surgery.

Authors:  Yoshihiro Moriya
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

4.  Coloanal anastomosis or abdominoperineal resection for very low rectal cancer: what will benefit, the surgeon's pride or the patient's quality of life?

Authors:  Rosa Digennaro; Mirna Tondo; Filippa Cuccia; Ivana Giannini; Francesco Pezzolla; Marcella Rinaldi; Dario Scala; Giovanni Romano; Donato F Altomare
Journal:  Int J Colorectal Dis       Date:  2012-12-30       Impact factor: 2.571

Review 5.  Latest Advances in Intersphincteric Resection for Low Rectal Cancer.

Authors:  Yifan Xv; Jiajun Fan; Yuan Ding; Yang Hu; Yingjie Hu; Zhengjie Jiang; Qingsong Tao
Journal:  Gastroenterol Res Pract       Date:  2020-07-20       Impact factor: 2.260

6.  Effect of neoadjuvant chemoradiation on postoperative fecal continence and anal sphincter function in rectal cancer patients.

Authors:  Alexander P Pietsch; Rainer Fietkau; Günther Klautke; Thomas Foitzik; Ernst Klar
Journal:  Int J Colorectal Dis       Date:  2007-05-12       Impact factor: 2.571

Review 7.  Pouch reconstruction in the pelvis.

Authors:  H-P Bruch; O Schwandner; S Farke; J Nolde
Journal:  Langenbecks Arch Surg       Date:  2003-03-25       Impact factor: 3.445

8.  Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome.

Authors:  C Coco; G Rizzo; C Mattana; M A Gambacorta; A Verbo; B Barbaro; F M Vecchio; D P Pafundi; M G Mastromarino; V Valentini
Journal:  Surg Endosc       Date:  2013-02-13       Impact factor: 4.584

9.  Functional results after radiochemotherapy and total mesorectal excision for rectal cancer.

Authors:  C Coco; V Valentini; A Manno; G Rizzo; M A Gambacorta; C Mattana; A Verbo; A Picciocchi
Journal:  Int J Colorectal Dis       Date:  2007-02-09       Impact factor: 2.796

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.